David Barba, MD
Orthopedic Surgery · Monterey Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 17 years
- University of California, Geffen School of Medicine, 2009
Offices
2 locations · Eastside Orthopedic Medical Associates · Kevin J Pelton MD Inc
Hospitals listed: Adventist Health White Memorial. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barba’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A135899 · Current
Licensed to practise in California · since 2015 · expires 2027-03-31 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health White MemorialLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health White Memorial
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.29) · 473 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.58 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.08 (101.25 to 214.92) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 163 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,433 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,215 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,320 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (0.46 to 5.23) · 632 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.58) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.96 (2.37 to 19.55) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.48 to 9.73) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.45 (0 to 1.22) · 2,746 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 207 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.403 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.034 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.673 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.803 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 257 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 517 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -34.6 · 74 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -21.5 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4 · 208 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 497 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 218 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9 to 16.4) · 199 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 51 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,008 patients answered, 10% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$110,120
Medicare paid this office $110,120 for 273 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 17 | $19,050 | $1,058 |
| Short return visit (20+ min) | 122 | $13,867 | $68 |
| Return visit (30+ min) | 97 | $13,459 | $100 |
| Aspiration and/or injection of fluid from large joint | 95 | $10,574 | $56 |
| New patient visit (45+ min) | 85 | $9,843 | $116 |
See all 16 services
| Replacement of knee joint, both sides of knee | 17 | $19,050 | $1,058 |
| Short return visit (20+ min) | 122 | $13,867 | $68 |
| Return visit (30+ min) | 97 | $13,459 | $100 |
| Aspiration and/or injection of fluid from large joint | 95 | $10,574 | $56 |
| New patient visit (45+ min) | 85 | $9,843 | $116 |
| Long return visit (40+ min) | 29 | $3,848 | $120 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $2,992 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,412 | $142 |
| X-ray of shoulder, minimum of 2 views | 50 | $1,670 | $28 |
| X-ray of knee, 1-2 views | 38 | $1,281 | $28 |
| X-ray of knee, 4 or more views | 19 | $847 | $35 |
| X-ray of knee, 3 views | 16 | $839 | $32 |
| X-ray of hip, 2-3 views | 17 | $763 | $36 |
| X-ray of both knees while standing | 15 | $515 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $31 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 46 | $9 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 36 | More than 69% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 110 | 109 | 76 | 58 | 169 | 189 |
| Replacement of knee joint, both sides of knee | 29 | – | 12 | 16 | 21 | 18 |
| Removal of extensive shoulder joint tissue using an endoscope | – | – | – | – | 11 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
273 Original Medicare patients in 2024. Average age 70 · Under 65 16% · 85 and older 10% · Women 76% · Also on Medicaid 93% · Health risk score 1.62. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 51% · Depression 30% · Coronary heart disease 25% · Chronic kidney disease 23% · Heart failure 19% · COPD 19% · Dementia 11% · Atrial fibrillation 8% · Cancer 7% · Stroke 7%.
The office billed $503,423, Medicare allowed $150,163 and paid $110,120; for 1,197 services of 55 kinds; $3,760 of it was for drugs given in the office and $106,360 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 273 | 1,197 | 70 | 1.62 | $503,423 | $110,120 |
| 2023 | 289 | 1,134 | 70 | 1.44 | $501,430 | $118,429 |
| 2022 | 229 | 712 | 70 | 1.38 | $372,396 | $90,434 |
| 2021 | 247 | 947 | 70 | 1.46 | $265,039 | $84,406 |
| 2020 | 238 | 1,177 | 70 | 1.94 | $290,367 | $97,006 |
| 2019 | 250 | 1,052 | 71 | 1.95 | $326,075 | $115,331 |
| 2018 | 224 | 730 | 71 | 2.00 | $251,808 | $82,476 |
| 2017 | 170 | 636 | 71 | 1.92 | $226,032 | $77,161 |
| 2016 | 180 | 577 | 72 | 1.86 | $193,545 | $64,481 |
| 2015 | 41 | 88 | 74 | 1.54 | $37,527 | $15,163 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Replacement of knee joint, both sides of knee | 21 | $22,800 | $1,086 |
| Return visit (30+ min) | 156 | $21,106 | $96 |
| Short return visit (20+ min) | 137 | $13,260 | $69 |
| Aspiration and/or injection of fluid from large joint | 95 | $8,973 | $53 |
| New patient visit (45+ min) | 43 | $5,687 | $132 |
| Removal of extensive shoulder joint tissue using an endoscope | 11 | $3,200 | $291 |
| Long return visit (40+ min) | 20 | $2,724 | $130 |
| X-ray of shoulder, minimum of 2 views | 43 | $1,836 | $30 |
| X-ray of knee, 1-2 views | 40 | $1,327 | $29 |
| New patient visit (30+ min) | 13 | $926 | $71 |
| X-ray of knee, 4 or more views | 15 | $731 | $41 |
| X-ray of hip, 2-3 views | 11 | $477 | $37 |
| Injection, methylprednisolone acetate, 20 mg | 16 | $107 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 29 | $80 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $3 | None |
2022: 12 services
| Return visit (30+ min) | 125 | $18,616 | $98 |
| Replacement of knee joint, both sides of knee | 16 | $17,176 | $1,074 |
| Short return visit (20+ min) | 94 | $8,957 | $68 |
| New patient visit (45+ min) | 32 | $4,097 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,674 | $167 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,779 | $48 |
| X-ray of shoulder, minimum of 2 views | 35 | $1,448 | $31 |
| Long return visit (40+ min) | 11 | $1,347 | $122 |
| X-ray of knee, 1-2 views | 30 | $1,304 | $28 |
| New patient visit (30+ min) | 12 | $828 | $69 |
| X-ray of hip, 2-3 views | 14 | $432 | $29 |
| Injection, methylprednisolone acetate, 20 mg | 16 | $56 | None |
2021: 15 services
| Short return visit (20+ min) | 148 | $14,821 | $63 |
| Replacement of knee joint, both sides of knee | 12 | $13,515 | $1,126 |
| Return visit (30+ min) | 78 | $10,522 | $103 |
| Aspiration and/or injection of fluid from large joint | 50 | $3,637 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,247 | $171 |
| New patient visit (45+ min) | 24 | $2,982 | $124 |
| New patient visit (30+ min) | 33 | $2,321 | $70 |
| X-ray of shoulder, minimum of 2 views | 42 | $1,549 | $29 |
| X-ray of knee, 1-2 views | 39 | $1,312 | $28 |
| X-ray of hip, 2-3 views | 13 | $598 | $40 |
| X-ray of both knees while standing | 14 | $535 | $36 |
| X-ray of knee, 3 views | 11 | $378 | $34 |
| Injection, methylprednisolone acetate, 20 mg | 18 | $84 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $12 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 13 | $0 | None |
2020: 12 services
| Short return visit (20+ min) | 157 | $15,679 | $56 |
| Return visit (30+ min) | 74 | $7,949 | $79 |
| Aspiration and/or injection of fluid from large joint | 55 | $5,246 | $48 |
| New patient visit (45+ min) | 44 | $4,734 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,025 | $151 |
| X-ray of shoulder, minimum of 2 views | 39 | $1,329 | $28 |
| New patient visit (30+ min) | 13 | $1,008 | $78 |
| X-ray of knee, 4 or more views | 14 | $847 | $38 |
| X-ray of knee, 1-2 views | 25 | $804 | $26 |
| Injection, methylprednisolone acetate, 20 mg | 18 | $73 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $58 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 22 | $1 | None |
2019: 12 services
| Replacement of knee joint, both sides of knee | 29 | $33,394 | $1,152 |
| Short return visit (20+ min) | 135 | $13,747 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,386 | $157 |
| New patient visit (45+ min) | 53 | $7,126 | $134 |
| Return visit (30+ min) | 55 | $6,168 | $82 |
| Aspiration and/or injection of fluid from large joint | 52 | $4,983 | $45 |
| X-ray of knee, 1-2 views | 40 | $1,469 | $28 |
| X-ray of shoulder, minimum of 2 views | 31 | $1,171 | $25 |
| Short return visit | 23 | $914 | $34 |
| X-ray of knee, 4 or more views | 16 | $794 | $38 |
| New patient visit (30+ min) | 11 | $793 | $72 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $43 | None |
2018: 12 services
| Replacement of knee joint, both sides of knee | 16 | $17,714 | $1,107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,116 | $157 |
| Short return visit (20+ min) | 96 | $7,814 | $54 |
| Return visit (30+ min) | 62 | $5,565 | $73 |
| New patient visit (45+ min) | 42 | $5,134 | $122 |
| Aspiration and/or injection of fluid from large joint | 45 | $3,464 | $47 |
| X-ray of knee, 1-2 views | 27 | $955 | $24 |
| Short return visit | 22 | $943 | $33 |
| New patient visit (30+ min) | 12 | $887 | $74 |
| X-ray of shoulder, minimum of 2 views | 25 | $742 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $28 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 12 | $0 | None |
2017: 12 services
| Replacement of knee joint, both sides of knee | 19 | $20,807 | $1,095 |
| Return visit (30+ min) | 59 | $6,087 | $79 |
| Short return visit (20+ min) | 73 | $5,918 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,072 | $163 |
| Aspiration and/or injection of fluid from large joint | 40 | $3,533 | $44 |
| New patient visit (45+ min) | 26 | $3,521 | $135 |
| New patient visit (30+ min) | 22 | $1,773 | $81 |
| X-ray of knee, 1-2 views | 28 | $1,100 | $26 |
| X-ray of shoulder, minimum of 2 views | 20 | $531 | $23 |
| Short return visit | 11 | $461 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $22 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 12 | $0 | None |
2016: 8 services
| New patient visit (45+ min) | 67 | $7,716 | $115 |
| Short return visit (20+ min) | 69 | $5,312 | $56 |
| Return visit (30+ min) | 47 | $5,203 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,145 | $159 |
| Aspiration and/or injection of fluid from large joint | 41 | $3,215 | $46 |
| X-ray of knee, 1-2 views | 49 | $2,085 | $26 |
| New patient visit (30+ min) | 16 | $1,217 | $76 |
| X-ray of shoulder, minimum of 2 views | 16 | $445 | $25 |
2015: 2 services
| New patient visit (45+ min) | 14 | $1,894 | $135 |
| New patient visit (30+ min) | 11 | $899 | $82 |
Medicaid work
$268,742 in 2024
Medicaid paid $268,742 for 4,796 billed services this clinician did in 2024, up to 106 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 931 | $98,291 |
| Short return visit (20+ min) | 1,039 | $64,072 |
| Return visit (30+ min) | 550 | $46,582 |
| Arthrocentesis and injection of knee joint | 693 | $31,791 |
| Radiologic examination, knee; complete, 4 or more views | 313 | $8,528 |
| X-RAY EXAM OF SHOULDER | 261 | $5,474 |
| Long return visit (40+ min) | 42 | $4,863 |
| Radiologic examination, knee; 3 views | 172 | $3,411 |
| New patient visit (30+ min) | 27 | $2,205 |
| X-ray of knee, anteroposterior and lateral views | 77 | $1,319 |
| New patient visit (60+ min) | 12 | $993 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 31 | $700 |
| 2024 | 4,796 | 16 | 106 | $268,742 |
| 2023 | 7,837 | 17 | 162 | $477,081 |
| 2022 | 6,910 | 19 | 231 | $453,303 |
| 2021 | 4,320 | 20 | 199 | $290,797 |
| 2020 | 3,131 | 12 | 96 | $152,282 |
| 2019 | 2,930 | 11 | 54 | $159,313 |
| 2018 | 1,740 | 12 | 53 | $61,792 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 2,081 | $145,516 |
| New patient visit (45+ min) | 742 | $90,829 |
| Return visit (30+ min) | 938 | $85,839 |
| Arthrocentesis and injection of knee joint | 1,214 | $61,756 |
| New patient visit (30+ min) | 446 | $38,189 |
| Long return visit (40+ min) | 185 | $21,938 |
| Radiologic examination, knee; complete, 4 or more views | 322 | $8,657 |
| X-RAY EXAM OF SHOULDER | 386 | $8,410 |
| Radiologic examination, knee; 3 views | 146 | $3,786 |
| X-ray of knee, anteroposterior and lateral views | 183 | $3,682 |
| New patient visit (60+ min) | 24 | $3,663 |
| Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views | 54 | $1,640 |
2022
| Short return visit (20+ min) | 2,429 | $164,940 |
| New patient visit (45+ min) | 679 | $76,486 |
| Return visit (30+ min) | 753 | $66,321 |
| Arthrocentesis and injection of knee joint | 1,176 | $57,217 |
| New patient visit (30+ min) | 575 | $45,722 |
| Long return visit (40+ min) | 163 | $18,783 |
| X-RAY EXAM OF SHOULDER | 354 | $6,528 |
| New patient visit (60+ min) | 30 | $4,518 |
| Radiologic examination, knee; 3 views | 186 | $3,379 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 120 | $2,466 |
| X-ray of knee, anteroposterior and lateral views | 176 | $2,448 |
| Radiologic examination, knee; both knees, standing, anteroposterior | 97 | $1,831 |
2021
| Short return visit (20+ min) | 2,250 | $155,366 |
| New patient visit (45+ min) | 305 | $40,113 |
| Arthrocentesis and injection of knee joint | 711 | $34,969 |
| Return visit (30+ min) | 195 | $18,493 |
| New patient visit (30+ min) | 217 | $17,041 |
| New patient visit (60+ min) | 47 | $9,664 |
| Long return visit (40+ min) | 42 | $4,651 |
| X-ray of knee, anteroposterior and lateral views | 119 | $2,490 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 34 | $2,354 |
| X-RAY EXAM OF SHOULDER | 137 | $2,139 |
| X-RAY EXAM OF FOOT | 31 | $646 |
| Radiologic examination, knee; complete, 4 or more views | 13 | $512 |
2020
| Short return visit (20+ min) | 1,718 | $91,193 |
| Arthrocentesis and injection of knee joint | 427 | $21,805 |
| Return visit (30+ min) | 255 | $18,703 |
| New patient visit (45+ min) | 136 | $17,190 |
| Lidocaine injection | 212 | $1,153 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 174 | $945 |
| Radiologic examination, knee; complete, 4 or more views | 12 | $771 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 21 | $215 |
| X-RAY EXAM OF SHOULDER | 12 | $153 |
| Infusion, normal saline solution , 1000 cc | 12 | $114 |
| Injection, methylprednisolone acetate, 20 mg | 28 | $40 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 124 | $0 |
2019
| Short return visit (20+ min) | 1,486 | $62,087 |
| Return visit (30+ min) | 489 | $46,146 |
| New patient visit (45+ min) | 290 | $34,101 |
| Arthrocentesis and injection of knee joint | 252 | $12,874 |
| New patient visit (30+ min) | 44 | $1,709 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 53 | $1,605 |
| Radiologic examination, knee; complete, 4 or more views | 15 | $305 |
| Lidocaine injection | 54 | $200 |
| X-RAY EXAM OF SHOULDER | 17 | $160 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 53 | $126 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 177 | $0 |
2018
| Short return visit (20+ min) | 1,067 | $28,037 |
| Return visit (30+ min) | 276 | $20,039 |
| Arthrocentesis and injection of knee joint | 104 | $3,648 |
| New patient visit (45+ min) | 28 | $3,128 |
| Service | 18 | $2,514 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $1,746 |
| New patient visit (30+ min) | 63 | $1,686 |
| Radiologic examination, knee; complete, 4 or more views | 17 | $446 |
| Service | 12 | $368 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $121 |
| Lidocaine injection | 24 | $59 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 79 | $0 |
Drugs they prescribed that Part D paid
$6,907
Pharmacies billed $6,907 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 21% of their Part D prescriptions (156 of 745) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
744 generic and fewer than 11 brand-name prescriptions · $6,907 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 117 | $1,372 | $12 |
| Ibuprofen | 156 | $1,260 | $8 |
| Ondansetron Odt | 85 | $1,204 | $14 |
| Hydrocodone-Acetaminophen | 128 | $811 | $6 |
| Meloxicam | 68 | $451 | $7 |
See all 9 drugs
| Diclofenac | 117 | $1,372 | $12 |
| Ibuprofen | 156 | $1,260 | $8 |
| Ondansetron Odt | 85 | $1,204 | $14 |
| Hydrocodone-Acetaminophen | 128 | $811 | $6 |
| Meloxicam | 68 | $451 | $7 |
| Gabapentin | 102 | $352 | $3 |
| Ibu | 11 | $98 | $9 |
| Naproxen | 21 | $87 | $4 |
| Tramadol | 22 | $52 | $2 |
Year by year
| 2024 | 745 | 285 | 21% (156) | None | $6,907 |
| 2023 | 678 | 268 | 22% (152) | None | $11,681 |
| 2022 | 288 | 115 | 15% (44) | 0% | $4,045 |
| 2021 | 232 | 94 | 35% (81) | 0% | $2,628 |
| 2020 | 315 | 132 | 44% (140) | None | $4,087 |
| 2019 | 369 | 162 | 51% (187) | 4% | $4,489 |
| 2018 | 479 | 182 | 37% (177) | 6% | $25,348 |
| 2017 | 369 | 149 | 27% (101) | None | $29,299 |
| 2016 | 163 | 81 | 29% (48) | None | $2,241 |
| 2015 | 18 | 13 | None | 0% | $116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Diclofenac | 130 | $2,912 | $22 |
| Ondansetron Odt | 65 | $2,000 | $31 |
| Ibuprofen | 156 | $1,900 | $12 |
| Hydrocodone-Acetaminophen | 114 | $1,143 | $10 |
| Meloxicam | 44 | $566 | $13 |
| Gabapentin | 80 | $447 | $6 |
| Naproxen | 16 | $156 | $10 |
| Acetaminophen-Codeine | 12 | $139 | $12 |
| Tramadol | 21 | $97 | $5 |
2022: 5 drugs
| Ibuprofen | 126 | $1,602 | $13 |
| Diclofenac | 29 | $569 | $20 |
| Ondansetron Odt | 25 | $544 | $22 |
| Hydrocodone-Acetaminophen | 29 | $332 | $11 |
| Gabapentin | 34 | $156 | $5 |
2021: 6 drugs
| Ibuprofen | 89 | $1,021 | $11 |
| Diclofenac | 31 | $713 | $23 |
| Hydrocodone-Acetaminophen | 41 | $342 | $8 |
| Acetaminophen-Codeine | 21 | $183 | $9 |
| Tramadol | 19 | $66 | $3 |
| Meloxicam | 13 | $48 | $4 |
2020: 5 drugs
| Diclofenac | 48 | $1,273 | $27 |
| Ibuprofen | 90 | $950 | $11 |
| Hydrocodone-Acetaminophen | 81 | $712 | $9 |
| Acetaminophen-Codeine | 24 | $248 | $10 |
| Tramadol | 35 | $170 | $5 |
2019: 8 drugs
| Voltaren | 13 | $702 | $54 |
| Ibuprofen | 77 | $688 | $9 |
| Hydrocodone-Acetaminophen | 79 | $676 | $9 |
| Diclofenac | 26 | $631 | $24 |
| Tramadol | 77 | $514 | $7 |
| Acetaminophen-Codeine | 28 | $286 | $10 |
| Ibu | 27 | $200 | $7 |
| Meloxicam | 16 | $53 | $3 |
2018: 10 drugs
| Lidocaine | 27 | $11,382 | $422 |
| Diclofenac | 57 | $6,216 | $109 |
| Lidocaine-Prilocaine | 19 | $2,189 | $115 |
| Voltaren | 19 | $1,937 | $102 |
| Hydrocodone-Acetaminophen | 86 | $1,155 | $13 |
| Ibu | 75 | $635 | $8 |
| Tramadol | 70 | $541 | $8 |
| Ibuprofen | 73 | $477 | $7 |
| Acetaminophen-Codeine | 20 | $267 | $13 |
| Meloxicam | 15 | $143 | $10 |
2017: 9 drugs
| Lidocaine | 31 | $13,074 | $422 |
| Diclofenac | 52 | $10,365 | $199 |
| Voltaren | 39 | $2,838 | $73 |
| Hydrocodone-Acetaminophen | 56 | $623 | $11 |
| Ibuprofen | 53 | $382 | $7 |
| Ibu | 49 | $348 | $7 |
| Acetaminophen-Codeine | 11 | $161 | $15 |
| Meloxicam | 19 | $124 | $7 |
| Tramadol | 34 | $122 | $4 |
2016: 5 drugs
| Voltaren | 13 | $643 | $49 |
| Ibuprofen | 76 | $574 | $8 |
| Hydrocodone-Acetaminophen | 34 | $484 | $14 |
| Tramadol | 13 | $56 | $4 |
| Meloxicam | 11 | $51 | $5 |
Money from drug and device companies
$216 in 2025
| 2025 | 2 | 17 | None | $216 |
| 2024 | 2 | 14 | None | $1,522 |
| 2023 | 3 | 6 | None | $177 |
| 2022 | 1 | 7 | None | $419 |
| 2021 | 1 | 4 | None | $221 |
| 2020 | 2 | 8 | None | $176 |
| 2019 | 3 | 3 | None | $109 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zynex Medical | Nexwave | $143 | 1 payment
|
| Stryker | Mako | $73 | 1 payment
|
See all 2 published payments
| Zynex Medical | Meals · 2025-12-31 | Nexwave | $143 |
| Stryker | Meals · 2025-11-19 | Mako | $73 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,522
| Medacta USA | Amistem H Femoral Stems | $1,230 | 8 payments
|
| Stryker | Mako | $293 | 6 payments
|
2023: $177
| Stryker | Gamma | $146 | 4 payments
|
| GlaxoSmithKline | Arexvy | $18 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $14 | 1 payment
|
2022: $419
| Stryker | Mako | $419 | 7 payments
|
2021: $221
| Stryker | Mako | $221 | 4 payments
|
2020: $176
| Stryker | Triathlon | $161 | 7 payments
|
| Ermi | None | $14 | 1 payment
|
2019: $109
| Camber Spine Technologies | None | $83 | 1 payment
|
| Amniox Medical | Neox | $13 | 1 payment
|
| Ermi | None | $12 | 1 payment
|
Professional record
- NPI
- 1205064722
- Licence
- CA A135899California A135899: Current · expires 2027-03-31
- Trained
- University of California, Geffen School of Medicine, 2009 · 17 years ago
- Group
- Eastside Orthopedic Medical Associates · Kevin J Pelton MD Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- IN 1205064722
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 471 W El Repetto Dr, Monterey Park, CA, 91754
- NPI first listed
- 2009-06-23
- NPI last updated
- 2015-07-28
This is when the NPI record was last certified, not a medical board exam.